|1.||Torrecilhas, Ana Claudia: 1 article (08/2015)|
|2.||Schenkman, Sergio: 1 article (08/2015)|
|3.||Moretti, Nilmar Silvio: 1 article (08/2015)|
|4.||Yoshida, Nobuko: 1 article (08/2015)|
|5.||Cano, Maria Isabel Nogueira: 1 article (08/2015)|
|6.||Antunes, Raysa Paes Pinto: 1 article (08/2015)|
|7.||da Silva Augusto, Leonardo: 1 article (08/2015)|
|8.||Clemente, Tatiana Mordente: 1 article (08/2015)|
|9.||Valiani, Ali: 1 article (12/2013)|
|10.||Mardani, Mohammad: 1 article (12/2013)|
12/27/2012 - "Discovery of salermide-related sirtuin inhibitors: binding mode studies and antiproliferative effects in cancer cells including cancer stem cells."
02/12/2009 - "We were finally able to ascribe the apoptotic effect of Salermide to the reactivation of proapoptotic genes epigenetically repressed exclusively in cancer cells by Sirt1. "
02/12/2009 - "Salermide was well tolerated by mice at concentrations up to 100 muM and prompted tumour-specific cell death in a wide range of human cancer cell lines. "
02/12/2009 - "Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect."
12/27/2012 - "When assayed in human leukemia MOLT4 as well as in human breast MDA-MB-231 and colon RKO cancer cell lines, the anilide 2b (salermide) and the phenylpropylthio analogue 4b emerged as the most potent antiproliferative agents. "
|2.||Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
|1.||TNF-Related Apoptosis-Inducing Ligand Receptors